Akari Therapeutics (CLA1) Q2 2026 Earnings Report
DE:CLA1 Q2 2026 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- -EUR 0.92
- Beat/Miss
- Beat by +EUR 0.92
- One Year Ago EPS
- -EUR 2.12
DE:CLA1 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
DE:CLA1 Upcoming Earnings
Akari Therapeutics's next earnings date is estimated for April 21, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:CLA1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 21, 2027 | 2026 (Q4) | ―- | -8.59 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.920.00 | -2.12 | 100.00% (+2.12) | |
| May 14, 2026 | 2026 (Q1) | ―- | -0.12 | ― | |
| Apr 07, 2026 | 2025 (Q4) | -1.17-1.17 | -4.76 | 75.37% (+3.59) | |
| Sep 25, 2025 | 2025 (Q2) | -0.08-0.11 | 0 | ― | |
| May 15, 2025 | 2025 (Q1) | ―- | 0 | ― | |
| Apr 16, 2025 | 2024 (Q4) | ―-4.76 | 0 | ― | |
| Aug 19, 2024 | 2024 (Q2) | ―0.00 | 0 | ― | |
| May 16, 2024 | 2024 (Q1) | ―- | 0 | ― | |
| Apr 01, 2024 | 2023 (Q4) | ―0.00 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed